EAS TIBIA SWISS AG

EAS TIBIA SWISS AG, established in 2024, is a vertically integrated company with a comprehensive strategy that spans the entire medical cannabis value chain, including cultivation, transformation, production, white label services, distribution, and research. Our company was founded to address the growing needs of the pharmaceutical industry in the realm of medical cannabis. We are committed to delivering GACP and GMP-certified medicinal cannabis products that are both innovative and market-leading, aimed at enhancing the quality of life for as many people as possible. At the heart of our success are our highly qualified, trained, and motivated employees who play a critical role in achieving our objectives. We ensure that our products, along with our entire organizational structure, adhere to the highest standards of compliance as required by the industry and applicable legislation (Art. 13 OCStup 812.121.1). To support this, we invest in robust Quality Control and a comprehensive Quality, Environment, and Safety Management System that underpins our strategy, decision-making, and continuous improvement across all production and commercial processes. Our Mission To provide premium medicinal cannabis products and solutions that meet the needs of our partners and customers, contributing to the health and well-being of patients. Our Vision To be the leading company in the medicinal cannabis industry, recognized for supplying premium, innovative, and competitive products and solutions.